Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Tregeutix Inc. logo — microbiota guided immunotherapy

Tregeutix Inc.

microbiota guided immunotherapy

Founded 2017 2 employees Biotechnology, Pharmaceutical

General Information

Company Name Tregeutix Inc.
Founded Year 2017
Employees 2
Industries Biotechnology, Pharmaceutical
Social

Get notified when Tregeutix Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Tregeutix Inc.

Tregeutix Inc. ("Tregeutix") is a biotech company whose mission is to create a future where autoimmune diseases and allergies can be safely and effectively managed through the strategic use of beneficial microbiota * species to guide the immune system. To achieve this goal, Tregeutix is developing a proprietary platform to discover beneficial microbes that can support antigen-specific regulatory T cells (Tregs **) using a combination of computational and experimental methods. By leveraging beneficial microbes, Tregeutix aims to restore the balance of the immune system and alleviate symptoms of autoimmune diseases and allergies, which are intrinsically antigen-specific pathologies. *Microbiota is the collection of microorganisms that live in and on our bodies, such as bacteria, fungi, and viruses. The microbiota influences many aspects of health, including immune system. Some microbiota species can induce or support Tregs.**Tregs are a type of white blood cell crucial for maintaining immune tolerance and preventing unwanted inflammation. They can suppress the activity of other immune cells implicated in autoimmune diseases and allergies.

No funding data available for Tregeutix Inc. yet.

Get notified when Tregeutix Inc. raises funding

Tregeutix Inc. Alternatives & Competitors

Tregeutix Inc. vs
Delinia
Delinia United States

Pioneering breakthrough treatments for autoimmune and inflammatory diseases with a focus on enhancin...

Acquired
3 employees
Biotechnology, Health and Wellness
Tregeutix Inc. vs
Greywolf Therapeutics
Greywolf Therapeutics United Kingdom

We are advancing novel antigen modulation technology that controls T cells to guide the immune syste...

Series B
49 employees
Biotechnology, Health Care
Tregeutix Inc. vs
AnTolRx
AnTolRx

Innovative therapies for autoimmune diseases through targeted immune-regulation using proprietary na...

Series A
Biotechnology, Health Care

FAQ About Tregeutix Inc.

microbiota guided immunotherapy
Tregeutix Inc. was founded in 2017.
Tregeutix Inc. operates in the following industries: Biotechnology, Pharmaceutical.
Tregeutix Inc. has approximately 2 employees.
Top alternatives and competitors to Tregeutix Inc. include Delinia, Greywolf Therapeutics, AnTolRx, COUR Pharma, Asylia Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Tregeutix Inc. and Delinia are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Tregeutix Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy